FINDINGS OF SCIENTIFIC MISCONDUCT Release Date: May 11, 1998 P.T. Department of Health and Human Services Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following cases: Cynthia King, Bienville Medical Group: Based on an investigation conducted by ORI\'s Division of Research Investigations, ORI found that Ms. King, staff assistant, Bienville Medical Group, engaged in scientific misconduct in clinical research conducted as part of a multicenter clinical trial supported by a National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) contract. Ms. King falsified and/or fabricated data and information collected from patients for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) at the clinical site in Terry, Mississippi. ORI acknowledges Ms. King\'s cooperation and assistance in completing its investigation. Ms. King has accepted the ORI finding and has entered into an Agreement with ORI in which she has voluntarily agreed, for the three year period beginning April 6, 1998: (1) to exclude herself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) that any institution that submits an application for PHS support for a research project on which Ms. King\'s participation is proposed or which uses her in any capacity on PHS supported research or that submits a report of PHS-funded research in which she is involved must concurrently submit a plan for supervision of her duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Ms. King\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI. No scientific publications were required to be corrected as part of this Agreement. Patrina Lowe, Bienville Medical Group: Based on an investigation conducted by ORI\'s Division of Research Investigations, ORI found that Ms. Lowe, former staff member, Bienville Medical Group, engaged in scientific misconduct in clinical research conducted as part of a multicenter clinical trial supported by a National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH) contract. Ms. Lowe falsified and/or fabricated data and information collected from patients for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) at the clinical site in Terry, Mississippi. ORI acknowledges Ms. Lowe\'s cooperation and assistance in completing its investigation. Ms. Lowe has accepted the ORI finding and has entered into an Agreement with ORI in which she has voluntarily agreed, for the three year period beginning April 6, 1998: (1) to exclude herself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant; and (2) that any institution that submits an application for PHS support for a research project on which Ms. Lowe\'s participation is proposed or which uses her in any capacity on PHS supported research or that submits a report of PHS-funded research in which she is involved must concurrently submit a plan for supervision of her duties to the funding agency for approval. The supervisory plan must be designed to ensure the scientific integrity of Ms. Lowe\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI. No scientific publications were required to be corrected as part of this Agreement. INQUIRIES For further information contact: Acting Director Division of Research Investigations Office of Research Integrity 5515 Security Lane, Suite 700 Rockville, MD 20852 Telephone: (301) 443-5330
